Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
ProSomnus Inc | OSA | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.47 | 0.47 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 0.34505 - 5.28 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 0.47 | USD |
ProSomnus Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
7.71M | 16.40M | - | 27.65M | -24.1M | -1.47 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
ProSomnus News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical OSA Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.50 | 0.60 | 0.47 | 0.47 | 62,565 | -0.03 | -6.00% |
1 Month | 0.6501 | 0.6501 | 0.47 | 0.562552 | 31,100 | -0.1801 | -27.70% |
3 Months | 0.75 | 0.8483 | 0.4616 | 0.600852 | 66,165 | -0.28 | -37.33% |
6 Months | 0.76 | 1.36 | 0.34505 | 0.9628246 | 1,036,495 | -0.29 | -38.16% |
1 Year | 5.11 | 5.28 | 0.34505 | 0.9779037 | 515,736 | -4.64 | -90.80% |
3 Years | 7.07 | 9.41 | 0.34505 | 1.01 | 376,995 | -6.60 | -93.35% |
5 Years | 7.07 | 9.41 | 0.34505 | 1.01 | 376,995 | -6.60 | -93.35% |
ProSomnus Description
Prosomnus Inc is a company engaged in the research of dental medical technology. The Company is principally engaged in the development, manufacture and marketing of precision intraoral medical devices. The Company's products include MicrO2 Sleep and Snore Device, IA Sleep and Snore Device, CA Sleep and Snore Device, PH Sleep and Snore Device and EVO Sleep and Snore Device, which are used in the treatment and management of mild to moderate obstructive sleep apnea disease. The Company's precision intraoral devices are personalized to each patient's anatomy and treatment plan. |